Request a Quote

News & Events

Dave John joins iSpecimen to drive next wave

of biospecimen procurement capabilities


Lifesciences data and informatics expert becomes

vice president of product management

LEXINGTON, MA, May 8 2019—Life sciences data and informatics expert Dave John has joined iSpecimen as vice president of product management.

Dave brings nearly two decades of experience in business development, product management, and executive leadership to the challenge of helping researchers procure human biospecimens for their work. Specimens encompass both inherent biological data (including genetics) as well as clinical information about the patients who provided them (including demographics, treatments and outcomes). Both data types help streamline discovery of increasingly specific specimens for specialized research.

“Specimen and patient data are fundamental to the biospecimen procurement process, much as product data enables the shopping experience on a consumer marketplace,” said iSpecimen Founder and CEO Christopher Ianelli, MD, PhD. “Dave’s experience with life sciences data, as well as his strong background bringing Software-as-a-Service products to market, will directly inform the capabilities delivered in the next generation of the iSpecimen Marketplace technology.”

Dave has extensive experience defining, designing, developing, and launching data science and informatics solutions for genomics, translational medicine, clinical trials, real-world evidence (RWE), and electronics health records (EHR/EMR).

Prior to joining iSpecimen, Dave served as vice president of analytics, RWE, & market access for Decision Resources Group. At DRG, he executed the business strategy for using international data sets for decisions about health care coverage and access. He previously held senior product management positions at PerkinElmer and ConvergeHEALTH by Deloitte.

“I’ve devoted my career to developing new products that improve health care,” said John. “iSpecimen exemplifies this purpose, and I look forward to helping streamline the sharing of biospecimens and the data that describes them to expedite important research.”

Dave earned bachelor’s degrees in chemistry and chemical engineering at Lehigh University and an MBA in finance at Northeastern University.

About iSpecimen

Headquartered in Lexington, MA, iSpecimen is the marketplace for human biospecimens, providing researchers with the specimens they need from the patients they want. The privately held company has developed the iSpecimen Marketplace, an online platform connecting healthcare organizations that have access to patients and specimens with the scientists who need them. Proprietary, cloud-based technology enables researchers to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. Researchers easily and compliantly gain access to specimens to drive scientific discovery. Partner sites gain an opportunity to contribute to biomedical discovery as well as their bottom line. Ultimately, healthcare advances for all. For more information about iSpecimen, please visit